Literature DB >> 2435288

Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoyl)anthranilic acid (N-5') in granulation tissue.

M Isaji, M Nakajoh, J Naito.   

Abstract

The effect of topically applied N-5', an inhibitor of chemical mediator release from mast cells, on the carrageenin-air-pouch inflammation was studied. The formation of granulation tissue, the accumulation of exudate and the number of infiltrating cells were significantly reduced by the treatment with N-5' (100 mg/kg). The collagen content in granulation tissue was dose-dependently reduced without affecting the noncollagen protein and DNA content by treatment with N-5'. At a dose of 100 mg/kg of N-5', prolyl hydroxylase activity in the tissue was significantly decreased. The selective inhibition of collagen accumulation in granulation tissue resulted from reduction of collagen biosynthesis in vivo. N-5' did not directly inhibit collagen synthesis by diploid fibroblasts, but inhibited fibroblast proliferation in culture. Such results indicate that one of the inhibitory mechanisms of collagen accumulation by N-5' in inflamed sites may involve the inhibition of fibroblast proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435288     DOI: 10.1016/0006-2952(87)90353-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

2.  Screening of potent inhibitors of collagen synthesis in cultured human skin fibroblasts.

Authors:  H Yamada; T Shigematsu; S Tajima; T Nishikawa
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  Idiopathic mediastinal fibrosis: report of a case.

Authors:  S Kinugasa; S Tachibana; M Kawakami; T Orino; R Yamamoto; S Sasaki
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  The prevention of postoperative intraperitoneal adhesions by tranilast: N-(3',4'-dimethoxycinnamoyl)anthranilic acid.

Authors:  S Adachi; T Maruyama; T Kondo; T Todoroki; K Fukao
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  A synthetic tryptophan metabolite reduces hemorrhagic area and inflammation after pulmonary radiofrequency ablation in rabbit nonneoplastic lungs.

Authors:  Hiroshi Nakada; Atsushi Yamashita; Masaomi Kuroki; Eiji Furukoji; Noriko Uchino; Taketoshi Asanuma; Yujiro Asada; Shozo Tamura
Journal:  Jpn J Radiol       Date:  2014-01-22       Impact factor: 2.374

Review 6.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 7.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

Review 8.  Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy.

Authors:  Michele Ammendola; Christian Leporini; Ilaria Marech; Cosmo Damiano Gadaleta; Giovanni Scognamillo; Rosario Sacco; Giuseppe Sammarco; Giovambattista De Sarro; Emilio Russo; Girolamo Ranieri
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

9.  Teucrium polium Extract Enhances the Anti-Angiogenesis Effect of Tranilast on Human Umbilical Vein Endothelial Cells.

Authors:  Fatemeh Sheikhbahaei; Mozafar Khazaei; Seyed Noureddin Nematollahi-Mahani
Journal:  Adv Pharm Bull       Date:  2018-03-18

10.  Effective treatment for prevention of post-operative adhesion after strabismus surgery in experimental rabbit model: 0.5 % tranilast ophthalmic solution.

Authors:  Sang Uk Choi; Kyoung Woo Kim; Nam Ju Moon
Journal:  BMC Ophthalmol       Date:  2016-09-21       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.